With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Focus Group in late 2020, a webinar series reviewing the current and emerging trends in cell and gene therapy was held virtually in May 2021. This webinar series was timely given the recent withdrawal of the United Kingdom from the European Union and the global COVID-19 pandemic impacting all sectors of the pharmaceutical sciences research landscape globally and in the UK. Delegates from the academic, industry, regulatory and NHS sectors attended the session where challenges and opportunities in the development and clinical implementation of cell and gene therapies were discussed. Globally, the cell and gene therapy market has reached a value of...
Gene and cell-based therapies (GCTs) are highly innovative therapies and hold great promise in the t...
The development of novel, affordable and efficacious therapeutics will be necessary to ensure the co...
The continued rapid progress of human gene and cell therapy in the latter half of the 2010s is fuele...
With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Foc...
With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Foc...
The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland o...
New technologies and therapies designed to facilitate development of personalized treatments are rap...
Abstract New technologies and therapies designed to facilitate development of personalized treatment...
Cell and gene therapies (CGTs) are progressively entering into clinical practice in different parts ...
The 2004 European Society of Gene Therapy (ESGT) meeting took place at Tampere Hall in Finland and h...
This is a report on a Patient Forum jointly hosted by the UK Medicines and Healthcare products Regul...
FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients mo...
2023 marks the 20th anniversary of the British Society for Gene and Cell Therapy. In these 20 years,...
In the last decade, many clinical trials with gene- and cell-based therapies were performed and incr...
International audienceFor the last 20 years, academic research has been the major, and often only, d...
Gene and cell-based therapies (GCTs) are highly innovative therapies and hold great promise in the t...
The development of novel, affordable and efficacious therapeutics will be necessary to ensure the co...
The continued rapid progress of human gene and cell therapy in the latter half of the 2010s is fuele...
With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Foc...
With the launch of the UK Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products Foc...
The second annual meeting of the Irish Society for Gene and Cell Therapy was held in Cork, Ireland o...
New technologies and therapies designed to facilitate development of personalized treatments are rap...
Abstract New technologies and therapies designed to facilitate development of personalized treatment...
Cell and gene therapies (CGTs) are progressively entering into clinical practice in different parts ...
The 2004 European Society of Gene Therapy (ESGT) meeting took place at Tampere Hall in Finland and h...
This is a report on a Patient Forum jointly hosted by the UK Medicines and Healthcare products Regul...
FDA approval of the first Chimeric Antigen Receptor T cell (CAR-T) therapy offers cancer patients mo...
2023 marks the 20th anniversary of the British Society for Gene and Cell Therapy. In these 20 years,...
In the last decade, many clinical trials with gene- and cell-based therapies were performed and incr...
International audienceFor the last 20 years, academic research has been the major, and often only, d...
Gene and cell-based therapies (GCTs) are highly innovative therapies and hold great promise in the t...
The development of novel, affordable and efficacious therapeutics will be necessary to ensure the co...
The continued rapid progress of human gene and cell therapy in the latter half of the 2010s is fuele...